Clinical Trials

53 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT03776032 2018-12-20

A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy

Classical hematologyThoracic

320 enrolled

Anemia, Lung Neoplasms

NCT00283621 2018-11-07

Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide

Phase NA Completed

51 enrolled

Sarcoma

NCT00416624 2017-02-10

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

Classical hematologyDermatologicLymphoidOther hematologic neoplasmOther neoplasmPlasma cell

239 enrolled 23 charts

Immunoglobulin Light-chain Amyloidosis, Anemia, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Leukemia, Mast-Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Mycosis Fungoides, Precancerous Conditions, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

NCT00327535 2016-08-11

A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.

153 enrolled

Anemia

NCT00077311 2016-06-30

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Classical hematologyThoracic

160 enrolled

Adenocarcinoma of Lung, Anemia, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neutropenia, Drug-Related Side Effects and Adverse Reactions

NCT00544232 2016-02-15

Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)

Classical hematologyGenitourinary

720 enrolled

Breast

Breast Neoplasms

NCT00381836 2015-12-04

Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer

Phase 2/3 Terminated

140 enrolled

Anemia, Fatigue, Neoplasms, Prostatic Neoplasms, Critical Illness

NCT00144755 2015-09-02

R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma

600 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00401544 2014-01-29

Darbepoetin Alfa With or Without Intravenous (IV) Iron

243 enrolled 26 charts

Anemia, Neoplasms

NCT00989092 2014-01-29

Darbepoetin Alfa and Anemia of Cancer

Phase 2 Terminated

287 enrolled 21 charts

Anemia, Carcinoma, Neoplasms

NCT00386152 2013-07-19

A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy

Phase 2 Terminated

235 enrolled 13 charts

Anemia, Neoplasms

NCT00144131 2013-05-24

Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy

750 enrolled

Anemia, Neoplasms

NCT00135317 2013-05-23

AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid Malignancies

Tumor-Agnostic

Neoplasms

NCT00148421 2013-05-15

Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.

Anemia

NCT00091858 2013-05-08

Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer

1,000 enrolled

Anemia, Neoplasms

NCT00111462 2013-05-08

Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy

Anemia, Neoplasms

NCT00540384 2013-05-08

Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy

Phase 1/2 Completed

405 enrolled

Anemia

NCT00118638 2013-04-29

A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy

705 enrolled

Anemia

NCT00540696 2013-04-26

Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa

300 enrolled

MyeloidOther hematologic neoplasm

Anemia

NCT00230321 2013-02-04

A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)

Phase 1/2 Completed

21 enrolled

Myelodysplastic Syndromes, Hematologic Neoplasms

NCT00344409 2012-08-31

A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients

200 enrolled

Anemia

NCT00359840 2012-08-31

A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor

120 enrolled

MyeloidOther hematologic neoplasm

Anemia

NCT01222195 2012-08-07

Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS)

Phase 2 Terminated

1 enrolled 5 charts

Leukemia, Myelodysplastic Syndromes

NCT00315484 2011-05-19

Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia

Phase 4 Completed

358 enrolled

Anemia

NCT00661999 2011-05-17

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

Classical hematologyDermatologicLymphoidOther hematologic neoplasmOther neoplasmPlasma cell

502 enrolled 30 charts

Immunoglobulin Light-chain Amyloidosis, Anemia, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Leukemia, Mast-Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Mycosis Fungoides, Precancerous Conditions, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

NCT00239239 2010-03-05

Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies

44 enrolled

Anemia, Neoplasms

NCT00261313 2010-02-26

ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer

80 enrolled

Breast

Breast Neoplasms

NCT00110955 2010-01-15

Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy

391 enrolled

Other hematologic neoplasm

Anemia

NCT00557817 2010-01-11

Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)

Phase 2/3 Completed

125 enrolled

Hematologic Neoplasms

NCT00036023 2009-05-11

Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

BreastLymphoidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Lung Neoplasms, Lymphoma, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00115167 2009-05-11

A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study

371 enrolled

Anemia, Neoplasms

NCT00117117 2009-03-25

A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®

Phase 4 Completed

2,423 enrolled

Anemia

NCT00120705 2009-03-25

Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy

204 enrolled

Anemia, Neoplasms

NCT00095277 2009-03-13

Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer

Classical hematologyPlasma cell

220 enrolled

Anemia, Neoplasms, Plasma Cell

NCT00355407 2009-03-13

Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation

Phase NA Completed

31 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT00204633 2009-02-16

Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP)

108 enrolled

Dysgerminoma

NCT00309920 2009-02-09

Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer

Phase NA Unknown

1,234 enrolled

Breast

Breast Neoplasms

NCT00117039 2008-10-15

A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia

Phase 4 Completed

1,500 enrolled

Anemia, Fatigue, Neoplasms

NCT00038064 2008-09-15

Anemia in Patients With a Non-Myeloid Malignancy

707 enrolled

Anemia, Neoplasms

NCT00119613 2008-08-08

A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa

600 enrolled

Thoracic

Neoplasms, Small Cell Lung Carcinoma

NCT00111137 2008-02-28

Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy

718 enrolled

Anemia, Neoplasms

NCT00117624 2007-12-28

A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy